PRESS RELEASE published on 03/12/2024 at 07:00, 2 years 1 month ago FUCHS concludes financial year 2023 with new record highs FUCHS concludes financial year 2023 with new record highs, achieving sales revenues of EUR 3,541 million and EBIT of EUR 413 million. Forecast for 2024 projects sales revenues around EUR 3.6 billion and EBIT around EUR 430 million EBIT Financial Year 2023 FUCHS SE Record Highs Sales Revenues
REGULATED PRESS RELEASE published on 03/12/2024 at 07:00, 2 years 1 month ago Biophytis annonce sa participation à plusieurs événements en Europe et aux Etats-Unis au cours des prochains mois Biophytis annonce sa participation à plusieurs événements en Europe et aux Etats-Unis au cours des prochains mois, dont des conférences scientifiques et des congrès de business development pour établir des partenariats. Découvrez les détails Biophytis Europe Participation États-Unis Événements
REGULATED PRESS RELEASE published on 03/12/2024 at 07:00, 2 years 1 month ago Biophytis announces its participation in several events in Europe and the United States over the coming months Biophytis to participate in key events in Europe and the USA, showcasing latest advancements in biotechnology and seeking partnerships for future growth Biophytis Biotechnology Partnerships Participation Events
PRESS RELEASE published on 03/12/2024 at 06:55, 2 years 1 month ago Operationally successful FY 2023 for TAG; sales results in Poland exceed guidance; significantly increased net liquidity from disposals in Germany; LTV stable despite portfolio devaluation TAG Immobilien AG reports successful FY 2023 with sales in Poland surpassing guidance and increased net liquidity from German disposals. LTV remains stable despite portfolio devaluation FY 2023 TAG Immobilien AG Sales Results Net Liquidity Portfolio Devaluation
PRESS RELEASE published on 03/12/2024 at 06:45, 2 years 1 month ago Galenica poursuit sa croissance au cours de l’exercice 2023 Le Groupe Galenica a enregistré une forte croissance du chiffre d'affaires de 4.4% au cours de l'exercice 2023 et prévoit une hausse de 8% à 11% pour l'EBIT ajusté en 2024. Détails dans le Rapport annuel 2023 Chiffre D'affaires Croissance EBIT Ajusté Rapport Annuel 2023 Galenica
PRESS RELEASE published on 03/12/2024 at 06:45, 2 years 1 month ago Galenica continues to grow in the 2023 financial year Galenica Group achieves 4.4% sales growth in 2023, proposing stable dividend. Expects 3-5% sales growth in 2024, increased adjusted EBIT by 8-11% 2024 Outlook Sales Growth Dividend Proposal Galenica Group Adjusted EBIT Increase
PRESS RELEASE published on 03/12/2024 at 06:45, 2 years 1 month ago PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow PolyPeptide announces record revenue growth of 43% in H2 2023 compared to H1 2023, along with enhanced profitability and cash flow. Details on 2023 results and 2024 guidance provided Revenue Growth Cash Flow Profitability 2023 Results PolyPeptide
PRESS RELEASE published on 03/12/2024 at 06:30, 2 years 1 month ago Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%
PRESS RELEASE published on 03/12/2024 at 06:30, 2 years 1 month ago Affluent Medical annonce le succès de la première implantation chez l’homme de son sphincter artificiel Artus pour le traitement de l’incontinence urinaire d’effort. Affluent Medical annonce le succès de la première implantation chez l'homme de son sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort Affluent Medical Dispositif Médical Incontinence Urinaire Artus Implantation
PRESS RELEASE published on 03/12/2024 at 06:30, 2 years 1 month ago Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence. Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence in Prague, Czech Republic. The innovative medical device offers hope for the estimated 400 million patients affected worldwide Medical Device Affluent Medical Urinary Incontinence Artus First-in-human Implantation
Published on 05/02/2026 at 21:00, 3 hours 27 minutes ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 22 hours 57 minutes ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 23 hours 37 minutes ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/02/2026 at 15:35, 8 hours 51 minutes ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 5 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 1 day 6 hours ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 04/30/2026 at 21:21, 2 days 3 hours ago CP -Mise à disposition du rapport financier annuel 2025
Published on 04/30/2026 at 20:00, 2 days 4 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 20:00, 2 days 4 hours ago AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Published on 04/30/2026 at 19:16, 2 days 5 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:16, 2 days 5 hours ago AXA annonce les résultats de son Assemblée Générale